German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0

ESMO Gastrointestinal Oncology Pub Date : 2025-03-01 Epub Date: 2025-01-06 DOI:10.1016/j.esmogo.2024.100112

M.P. Ebert , W. Fischbach , S. Hollerbach , J. Höppner , D. Lorenz , M. Stahl , M. Stuschke , O. Pech , U. Vanhoefer , C. Bruns , C. Ell , M. Follmann , U. Goerling , L. Grenacher , J. Haardt , A.H. Hölscher , R. Hummel , W.T. Knoefel , J. Körber , R. Langer , R. Porschen

{"title":"German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0","authors":"M.P. Ebert , W. Fischbach , S. Hollerbach , J. Höppner , D. Lorenz , M. Stahl , M. Stuschke , O. Pech , U. Vanhoefer , C. Bruns , C. Ell , M. Follmann , U. Goerling , L. Grenacher , J. Haardt , A.H. Hölscher , R. Hummel , W.T. Knoefel , J. Körber , R. Langer , R. Porschen","doi":"10.1016/j.esmogo.2024.100112","DOIUrl":null,"url":null,"abstract":"<div><div>This guideline for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus was developed and managed by the German Guideline Program in Oncology (GGPO) of the Association of the Scientific Medical Societies in Germany (AWMF), German Cancer Society (DKG), and German Cancer Aid (DKH). The guideline commission comprised multidisciplinary experts from various professional associations and organizations involved in the management of esophageal cancer, as well as a patient representative. Quality of the evidence is presented using Oxford evidence-based medicine system, and recommendations were graded in a formal consensus process using a recommendation grading scheme.</div></div>","PeriodicalId":100490,"journal":{"name":"ESMO Gastrointestinal Oncology","volume":"7 ","pages":"Article 100112"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Gastrointestinal Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949819824000736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

This guideline for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus was developed and managed by the German Guideline Program in Oncology (GGPO) of the Association of the Scientific Medical Societies in Germany (AWMF), German Cancer Society (DKG), and German Cancer Aid (DKH). The guideline commission comprised multidisciplinary experts from various professional associations and organizations involved in the management of esophageal cancer, as well as a patient representative. Quality of the evidence is presented using Oxford evidence-based medicine system, and recommendations were graded in a formal consensus process using a recommendation grading scheme.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

德国食管鳞状细胞癌和腺癌诊断和治疗指南- 4.0版

本食管鳞状细胞癌和腺癌的诊断和治疗指南由德国科学医学学会协会（AWMF）、德国癌症协会（DKG）和德国癌症援助协会（DKH）的德国肿瘤学指南项目（GGPO）制定和管理。指南委员会由来自食管癌管理的各种专业协会和组织的多学科专家以及一名患者代表组成。证据质量采用牛津循证医学系统，建议在正式的共识过程中使用建议分级方案进行分级。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ESMO Gastrointestinal Oncology

自引率

0.00%

发文量